Recruiting now—Ages 18 Years and up
Development of a Radiomics Model With MR to Predict the Occurence of a Infiltration of Muscoskeletal Tumor
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06774729 on ClinicalTrials.gov ↗
Conditions studied
Soft Tissue Sarcoma (STS)Bone Cancer Tumor
Where it's running1 site
1 international site
- Recruiting now
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Italy 40138
- Vincenzo Lucidi, MD(contact)+39 3385246923[email protected]
See the official eligibility language
Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.
Inclusion Criteria: * Age over 18 * suspect of soft tissue sarcoma with a indication for surgical treatment * suspect of bone cancer tumor with a indication for surgical treatment * To give informed consent Exclusion Criteria: * simultaneous cancer or history of cancer in the last 5 years * acute or chronic serious conditions that could * contraindication to conduct a Contrast-enhanced magnetic resonance imaging (MRI) such as: * renal failure without dialysis * history of allergy to a paramagnetic contrast agent * claustrophobia * symptomatic epilepsy or history of epilepsy * cardiac pacemaker * infusion pump, prosthesis or any implant not compatible with MRI * pregnancy
Updated 2025-01-14 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.